StartUp Health February 11, 2025
A member of the StartUp Health Community, Miist Therapeutics develops inhaled therapies – starting with smoking cessation and migraine relief – that are faster acting and more effective than today’s standard of care.
Miist Therapeutics, a member of the StartUp Health community that is a developer of inhaled medicines, raised $7M in seed funding from Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First, California Innovation Fund, and other investors. Miist has clinically validated its approach and is currently advancing two assets for the treatment of smoking addiction and migraine. source>
Other global health innovation funding reported this week included:
Berry Street, a New York, NY-based nutrition counseling platform, raised $50M from Northzone, Sofina, and FJ Labs. source>
Fay, a San...
Today's Sponsors
Today's Sponsor